1) May provide clinical benefits in areas such as growth and bone density
2) imo
Combination positive for exon skipping drugs and now could enhance gene therapy drugs as well…
Atl1102 ( win win)$$
..
Ann: ATL1102 Data presented at MDA Annual Conference, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.87M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 1.0¢ | $5.737K | 573.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3633138 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 3174000 | 4 |
View Market Depth
| Last trade - 15.22pm 17/06/2025 (20 minute delay) ? |
| PER (ASX) Chart |